Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Director/PDMR Shareholding

25 Apr 2019 16:40

RNS Number : 1533X
Zotefoams PLC
25 April 2019
 

Zotefoams plc

(the 'Company')

 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PDMRs

 

Further to the announcement made on 16 April 2019, the Company has received notice from its Employee Benefit Trust of the further sale for tax of nil cost options granted over ordinary shares of 5 pence each ('Shares') under the Company's 2012 Deferred Bonus Share Plan ('DBSP') and 2007 Long-Term Incentive Plan ('LTIP') by Mr D B Stirling and Mr G C McGrath as follows:

 

Director

 

Shares sold for tax

Sale price (£)

Date

D B Stirling

12,051

20,757

£5.7000

£5.740826

18 April 2019

24 April 2019

G C McGrath

7,049

12,142

£5.7000

£5.740826

18 April 2019

24 April 2019

 

The Notification of Dealing Form for Mr Stirling and Mr McGrath can be found below.

 

This notification is made in accordance with the Market Abuse Regulation.

 

Enquiries:

James Adams

Interim Company Secretary

Zotefoams plc

 

25 April 2019

 

020 8664 1600

 

About Zotefoams plc:

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology. Using a unique manufacturing process with environmentally friendly nitrogen expansion, Zotefoams produces and sells lightweight AZOTE® polyolefin and ZOTEK® high-performance foams for diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. In addition, Zotefoams owns and licenses patented MuCell® microcellular foam technology, developed specifically for extrusion applications, from a base in Massachusetts, USA to customers worldwide.

 

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky and Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT®).

 

www.zotefoams.com

 

AZOTE®, ZOTEK®, T-FIT® are registered trademarks of Zotefoams plc

MuCell® is a registered trademark of Trexel Inc.

 

 

ZOTEFOAMS PLC

DEALING NOTIFICATION FORMFOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: David Stirling

2.

Reason for the notification

a)

Position/status: Group CEO

b)

Initial notification/Amendment: Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Zotefoams plc

b)

LEI: 213800B6P256B5XN8D32

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Exercise and sale for tax under the Long-Term Incentive Plan

c)

Price(s) and volume(s):

Price(s)

Volume(s)

£5.70

10,846

d)

Aggregated information:

 

Aggregate Price

Aggregate Volume

Aggregate Total

£5.70

10,846

£61,822.20

e)

Date of the transaction: 18 April 2019

f)

Place of the transaction: XLON

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Exercise and sale for tax under the Deferred Bonus Share Plan

c)

Price(s) and volume(s):

Price(s)

Volume(s)

£5.70

1,205

d)

Aggregated information:

 

Aggregate Price

Aggregate Volume

Aggregate Total

£5.70

1,205

£6,868.5

e)

Date of the transaction: 18 April 2019

f)

Place of the transaction: XLON

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Exercise and sale for tax under the Long-Term Incentive Plan

c)

Price(s) and volume(s):

Price(s)

Volume(s)

£5.740826

18,681

d)

Aggregated information:

 

Aggregate Price

Aggregate Volume

Aggregate Total

£5.740826

18,681

£107,244.37

e)

Date of the transaction: 24 April 2019

f)

Place of the transaction: XLON

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Exercise and sale for tax under the Deferred Bonus Share Plan

c)

Price(s) and volume(s):

Price(s)

Volume(s)

£5.740826

2,076

d)

Aggregated information:

 

Aggregate Price

Aggregate Volume

Aggregate Total

£5.740826

2,076

£11.917.95

e)

Date of the transaction: 24 April 2019

f)

Place of the transaction: XLON

 

 

 

ZOTEFOAMS PLC

DEALING NOTIFICATION FORMFOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Gary McGrath

2.

Reason for the notification

a)

Position/status: Group CFO

b)

Initial notification/Amendment: Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Zotefoams plc

b)

LEI: 213800B6P256B5XN8D32

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Exercise and sale for tax under the Long-Term Incentive Plan

c)

Price(s) and volume(s):

Price(s)

Volume(s)

£5.70

7,049

d)

Aggregated information:

 

Aggregate Price

Aggregate Volume

Aggregate Total

£5.70

7,049

£40,179.30

e)

Date of the transaction: 18 April 2019

f)

Place of the transaction: XLON

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Exercise and sale for tax under the Long-Term Incentive Plan

c)

Price(s) and volume(s):

Price(s)

Volume(s)

£5.740826

12,142

d)

Aggregated information:

 

Aggregate Price

Aggregate Volume

Aggregate Total

5.740826

12,142

£69,705.11

e)

Date of the transaction: 24 April 2019

f)

Place of the transaction: XLON

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHEASLSADSNEFF

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.